Goodrx logo

Goodrx Share Price Today

(NASDAQ: GDRX)

Goodrx share price is $4.94 & ₹429.63 as on 6 Mar 2025, 2.30 'hrs' IST

$4.94

0.27

(5.78%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Goodrx share price in Dollar and Rupees. Guide to invest in Goodrx stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Goodrx, along with analyst recommendations, forecasts, and comprehensive financials.

Goodrx share price movements

  • Today's Low: $4.70
    Today's High: $4.96

    Day's Volatility :5.24%

  • 52 Weeks Low: $4.09
    52 Weeks High: $9.26

    52 Weeks Volatility :55.83%

Goodrx (GDRX) Returns

PeriodGoodrx Holdings, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-4.69%
2.1%
0.0%
6 Months
-41.55%
-4.1%
0.0%
1 Year
-38.31%
2.2%
0.0%
3 Years
-67.55%
11.8%
-11.6%

Goodrx (GDRX) Key Statistics

in dollars & INR

Previous Close
$4.67
Open
$4.7
Today's High
$4.96
Today's Low
$4.7
Market Capitalization
$1.9B
Today's Volume
$416.8K
52 Week High
$9.2599
52 Week Low
$4.09
Revenue TTM
$792.3M
EBITDA
$157.8M
Earnings Per Share (EPS)
$0.04
PE Ratio
121.25
Profit Margin
2.07%
Quarterly Earnings Growth YOY
-0.87%
Return On Equity TTM
2.2%

How to invest in Goodrx Stock (GDRX) from India?

It is very easy for Indian residents to invest directly in Goodrx from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Goodrx stock in both Indian Rupees (INR) and US Dollars (USD). Search for Goodrx or GDRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Goodrx or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Goodrx shares which would translate to 0.176 fractional shares of Goodrx as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Goodrx, in just a few clicks!

Returns in Goodrx (GDRX) for Indian investors in Rupees

The Goodrx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Goodrx investment value today

Current value as on today

₹70,220

Returns

₹29,780

(-29.78%)

Returns from Goodrx Stock

₹34,742 (-34.74%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Goodrx (GDRX)

13%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Goodrx Stock from India on INDmoney has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Goodrx

  • Francisco Partners Management LP

    18.27%

  • Vanguard Group Inc

    2.18%

  • Rubric Capital Management LP

    1.51%

  • Lakewood Capital Management, LP

    1.27%

  • Ameriprise Financial Inc

    1.25%

  • SILVER LAKE GROUP, L.L.C.

    0.92%

Analyst Recommendation on Goodrx

Buy

    57%Buy

    38%Hold

    3%Sell

Based on 26 Wall street analysts offering stock ratings for Goodrx(by analysts ranked 0 to 5 stars)

Based on 26 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
14
11
Hold
10
11
13
Sell
1
1
1

Analyst Forecast on Goodrx Stock (GDRX)

What analysts predicted

Upside of 35.75%

Target:

$6.71

Current:

$4.94

Insights on Goodrx Stock (Ticker Symbol: GDRX)

  • Price Movement

    In the last 6 months, GDRX stock has moved down by -41.6%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 195.25M → 198.58M (in $), with an average increase of 1.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 6 quarters, -38.49M → 16.07M (in $), with an average increase of 539.4% per quarter
  • GDRX vs DOCS (1 yr)

    In the last 1 year, Doximity, Inc. has given 144.5% return, outperforming this stock by 183.1%
  • GDRX vs HQY (3 yr)

    In the last 3 years, Healthequity Inc has given 39.9% return, outperforming this stock by 110.7%
  • Price to Sales

    ForGDRX every $1 of sales, investors are willing to pay $2.3, whereas for Doximity, Inc., the investors are paying $23.0 for every $1 of sales.

GDRX Goodrx Financials in INR & Dollars

FY19Y/Y Change
Revenue
$388.2M
↑ 55.59%
Net Income
$66.0M
↑ 50.82%
Net Profit Margin
17.01%
↓ 0.54%
FY20Y/Y Change
Revenue
$550.7M
↑ 41.85%
Net Income
$-293.6M
↓ 544.56%
Net Profit Margin
-53.32%
↓ 70.33%
FY21Y/Y Change
Revenue
$745.4M
↑ 35.36%
Net Income
$-25.3M
↓ 91.4%
Net Profit Margin
-3.39%
↑ 49.93%
FY22Y/Y Change
Revenue
$766.6M
↑ 2.83%
Net Income
$-32.8M
↑ 29.99%
Net Profit Margin
-4.28%
↓ 0.89%
FY23Y/Y Change
Revenue
$750.3M
↓ 2.12%
Net Income
$-8.9M
↓ 72.99%
Net Profit Margin
-1.18%
↑ 3.1%
FY24Y/Y Change
Revenue
$792.3M
↑ 5.61%
Net Income
$46.5M
↓ 624.7%
Net Profit Margin
5.87%
↑ 7.05%
Q3 FY23Q/Q Change
Revenue
$180.0M
↓ 5.12%
Net Income
$-38.5M
↓ 165.48%
Net Profit Margin
-21.39%
↓ 52.38%
Q4 FY23Q/Q Change
Revenue
$196.6M
↑ 9.27%
Net Income
$-25.9M
↓ 32.8%
Net Profit Margin
-13.16%
↑ 8.23%
Q1 FY24Q/Q Change
Revenue
$197.9M
↑ 0.63%
Net Income
$-1.0M
↓ 96.1%
Net Profit Margin
-0.51%
↑ 12.65%
Q2 FY24Q/Q Change
Revenue
$200.6M
↑ 1.38%
Net Income
$6.7M
↓ 763.43%
Net Profit Margin
3.34%
↑ 3.85%
Q3 FY24Q/Q Change
Revenue
$195.3M
↓ 2.67%
Net Income
$12.3M
↑ 83.13%
Net Profit Margin
6.28%
↑ 2.94%
Q4 FY24Q/Q Change
Revenue
$198.6M
↑ 1.71%
Net Income
$16.1M
↑ 31.15%
Net Profit Margin
8.1%
↑ 1.82%
FY19Y/Y Change
Profit
$374.2M
↑ 53.69%
FY20Y/Y Change
Profit
$521.1M
↑ 39.26%
FY21Y/Y Change
Profit
$698.7M
↑ 34.08%
FY22Y/Y Change
Profit
$701.5M
↑ 0.4%
FY23Y/Y Change
Profit
$683.3M
↓ 2.59%
FY24Y/Y Change
Profit
$744.1M
↑ 8.89%
Q3 FY23Q/Q Change
Profit
$161.2M
↓ 6.98%
Q4 FY23Q/Q Change
Profit
$139.1M
↓ 13.71%
Q1 FY24Q/Q Change
Profit
$169.5M
↑ 21.8%
Q2 FY24Q/Q Change
Profit
$171.8M
↑ 1.36%
Q3 FY24Q/Q Change
Profit
$183.6M
↑ 6.86%
Q4 FY24Q/Q Change
Profit
$186.4M
↑ 1.54%
FY19Y/Y Change
Operating Cash Flow
$83.3M
↑ 84.05%
Investing Cash Flow
$-37.1M
↑ 971.57%
Financing Cash Flow
$-54.8M
↑ 121.48%
FY20Y/Y Change
Operating Cash Flow
$131.3M
↑ 57.7%
Investing Cash Flow
$-91.6M
↑ 147.25%
Financing Cash Flow
$905.8M
↓ 1753.52%
FY21Y/Y Change
Operating Cash Flow
$178.8M
↑ 36.12%
Investing Cash Flow
$-178.7M
↑ 95.09%
Financing Cash Flow
$-30.5M
↓ 103.37%
FY22Y/Y Change
Operating Cash Flow
$146.8M
↓ 17.9%
Investing Cash Flow
$-210.5M
↑ 17.77%
Financing Cash Flow
$-120.2M
↑ 293.82%
Q2 FY23Q/Q Change
Operating Cash Flow
$29.9M
↓ 7.5%
Investing Cash Flow
$-15.0M
↑ 4.7%
Financing Cash Flow
$-14.0M
↓ 0.68%

Goodrx Technicals Summary

Sell

Neutral

Buy

Goodrx is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Goodrx (GDRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Goodrx Holdings, Inc. logo
-0.64%
-41.55%
-38.31%
-67.55%
-90.75%
Doximity, Inc. logo
14.77%
90.0%
141.3%
29.72%
27.98%
Solventum Corp logo
7.35%
20.41%
14.31%
14.31%
14.31%
Ge Healthcare Technologies Inc. logo
-3.66%
-3.41%
-9.44%
39.38%
39.38%
Veeva Systems Inc. logo
-6.4%
1.46%
-2.72%
20.36%
57.16%
Healthequity Inc logo
-6.64%
29.56%
27.86%
101.62%
87.19%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Goodrx Holdings, Inc. logo
121.25
121.25
NA
0.4
0.02
0.04
NA
1.9
Doximity, Inc. logo
68.45
68.45
3.81
1.31
0.21
0.13
NA
5.5
Solventum Corp logo
29.04
29.04
NA
5.52
0.07
0.05
NA
17.13
Ge Healthcare Technologies Inc. logo
19.92
19.92
2.29
4.68
0.26
0.06
0.0
18.48
Veeva Systems Inc. logo
53.93
53.93
1.25
6.45
0.13
0.07
NA
33.93
Healthequity Inc logo
100.79
100.79
1.21
3.15
0.05
0.04
NA
24.47
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Goodrx Holdings, Inc. logo
Buy
$1.9B
-90.75%
121.25
2.07%
Doximity, Inc. logo
Hold
$12.8B
27.98%
68.45
36.6%
Solventum Corp logo
Hold
$13.9B
14.31%
29.04
5.8%
Ge Healthcare Technologies Inc. logo
Buy
$39.5B
39.38%
19.92
10.13%
Veeva Systems Inc. logo
Buy
$35.5B
57.16%
53.93
25.07%
Healthequity Inc logo
Buy
$9.5B
87.19%
100.79
8.41%

About Goodrx

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Organization
Goodrx
Employees
0
CEO
Ms. Wendy Barnes
Industry
Technology Services

Management People of Goodrx

NameTitle
Mr. Trevor Bezdek
Co-founder & Co-Chairman of the Board
Mr. Douglas Joseph Hirsch
Co-founder & Director
Mr. Romin Nabiey
Chief Accounting Officer
Mr. Bansi Nagji
President of Healthcare
Ms. Wendy Barnes
President, CEO & Director
Mr. Christopher A. McGinnis
CFO & Treasurer
Mr. Nitin Shingate
Chief Technology Officer
Ms. Aubrey Reynolds
Director of Investor Relations
Ms. Gracye Cheng
Senior VP, General Counsel & Secretary
Mr. Ryan Sullivan
Chief Marketing Officer

Important FAQs about investing in GDRX Stock from India :

What is Goodrx share price today?

Goodrx share price today stands at $4.94, Open: $4.70 ; Previous Close: $4.67 ; High: $4.96 ; Low: $4.70 ; 52 Week High: $9.26 ; 52 Week Low: $4.09.

The stock opens at $4.70, after a previous close of $4.67. The stock reached a daily high of $4.96 and a low of $4.70, with a 52-week high of $9.26 and a 52-week low of $4.09.

Can Indians buy Goodrx shares?

Yes, Indians can invest in the Goodrx (GDRX) from India.

With INDmoney, you can buy Goodrx at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Goodrx at zero transaction cost.

How can I buy Goodrx shares from India?

It is very easy to buy Goodrx from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Goodrx (GDRX) be purchased?

Yes, you can buy fractional shares of Goodrx with INDmoney app.

What are the documents required to start investing in Goodrx stocks?

To start investing in Goodrx, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Goodrx Stock (GDRX)?

Today’s highest price of Goodrx (GDRX) is $4.96.

Today’s lowest price of Goodrx (GDRX) is $4.70.

What is today's market capitalisation of Goodrx?

Today's market capitalisation of Goodrx GDRX is 1.9B

What is the 52 Week High and Low Range of Goodrx Stock (GDRX)?

  • 52 Week High

    $9.26

  • 52 Week Low

    $4.09

What are the historical returns of Goodrx (GDRX)?

  • 1 Month Returns

    -0.64%

  • 3 Months Returns

    -41.55%

  • 1 Year Returns

    -38.31%

  • 5 Years Returns

    -90.75%

Who is the Chief Executive Officer (CEO) of Goodrx ?

Ms. Wendy Barnes is the current Chief Executive Officer (CEO) of Goodrx.